New inhaled peptide aims to halt lung scarring in IPF patients
NCT ID NCT06968845
First seen Feb 03, 2026 · Last updated May 25, 2026 · Updated 9 times
Summary
This study tests an experimental inhaled medication called LTI-03 in people with idiopathic pulmonary fibrosis (IPF), a progressive lung-scarring disease. The drug aims to protect lung cells and reduce scarring. About 120 adults aged 40+ with IPF diagnosed within the last 5 years will receive either LTI-03 or a placebo for 24 weeks to check safety and effects on lung function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS (IPF) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
El Paso Pulmonary Association
RECRUITINGEl Paso, Texas, 79902, United States
Contact
Contact Email: •••••@•••••
-
Henry Ford Health
RECRUITINGDetroit, Michigan, 48202, United States
Contact
Contact Email: •••••@•••••
-
Launceston Respiratory and Sleep Centre
RECRUITINGLaunceston, Tasmania, 7250, Australia
Contact
Contact Email: •••••@•••••
-
Medical University of South Carolina
RECRUITINGCharleston, South Carolina, 29425, United States
Contact Email: •••••@•••••
Contact
-
Paradigm Clinical Research Centers, LLC
RECRUITINGSan Diego, California, 92108, United States
Contact Email: •••••@•••••
Contact
-
Royal Infirmary of Edinburgh
RECRUITINGEdinburgh, Scotland, EH16 4SA, United Kingdom
Contact
Contact Email: •••••@•••••
-
Salus Aegroti Praktyka Lekarska dr n. med. Grzegorz Gąsior
RECRUITINGSosnowiec, Silesian Voivodeship, 41-208, Poland
Contact
Contact Email: •••••@•••••
-
The Lung Research Center, LLC
RECRUITINGChesterfield, Missouri, 63017, United States
Contact Email: •••••@•••••
Contact
-
UAB Lung Health Center
RECRUITINGBirmingham, Alabama, 35233, United States
Contact Email: •••••@•••••
Contact
-
University of Kansas Medical Center
RECRUITINGKansas City, Missouri, 66160, United States
Contact Email: •••••@•••••
Contact
-
Yale University School of Medicine
RECRUITINGNew Haven, Connecticut, 06511, United States
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.